As of 2025-07-06, the Relative Valuation of Valeo Pharma Inc (VPH.CN) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.59 CAD, the upside of Valeo Pharma Inc based on Relative Valuation is -103.8%.
The range of the Relative Valuation is (0.02) - (0.33) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 1.5x | 0.1x |
| Forward P/E multiples | 0.1x - 1.5x | 0.1x |
| Fair Price | (0.02) - (0.33) | (0.02) |
| Upside | -103.1% - -156.0% | -103.8% |
| Date | P/E |